I think CYDY's "diversion" into COVID has helped the cancer trials by generating more exposure for the company and Dr. Patterson and funneling patients into the trials. The large number of stockholders spreading the word about cancer has been important. COVID may seem like it has side tracked the other indications, but I think not if they can keep them going in parallel.